A biotechnology company focused on the research and development of novel therapeutics, primarily targeting cancer and immune-related diseases. The firm’s valuation and investor interest tend to hinge on clinical trial progress, regulatory milestones, and partnerships that can help advance its drug p...
No congressional trades have been disclosed for INNMF (IN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.